Prognostic value of serum IL-8 and IL-10 in patients with ovarian cancer undergoing chemotherapy
Authors:
Open Access
- 18 December 2018
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 17 (2) , 2365-2369
Abstract
Prognostic value of serum interleukin-8 (IL-8) and interleukin-10 (IL-10) in patients with ovarian cancer undergoing chemotherapy was evaluated. The clinical data of ovarian tumor patients in Yidu Central Hospital of Weifang treated from January 2012 to December 2014 was retrospectively analyzed, 92 cases of which were malignant group, 64 cases were benign group, and 58 healthy subjects were selected as control group. Serum expression levels of IL-8 and IL-10 of the three groups were detected by enzyme-linked immunosorbent assay. Serum expression levels of IL-8 and IL-10 in benign and malignant groups both were higher than those in healthy control group (P<0.001). Serum expression levels of IL-8 and IL-10 of patients with ovarian cancer at III+IV stage were higher than that at I+II stage (P<0.001). Serum expression levels of IL-8 and IL-10 of patients with malignant ovarian tumors before chemotherapy were higher than those after chemotherapy (P<0.001). Serum levels of IL-8 and IL-10 of patients with malignant ovarian tumors in stable condition after chemotherapy were lower than those with recurrence and metastasis after chemotherapy (P<0.001). The median of serum expression levels of IL-8 and IL-10 was divided into low expression group and high expression group. The survival time of patients in high serum IL-8 and IL-10 expression group was significantly shorter than that in serum IL-8 and IL-10 low expression group (P<0.05). The survival time was negatively correlated with the expression levels of IL-8 and IL-10. Serum expression levels of IL-8 and IL-10 are closely related to the stages and prognosis of ovarian cancer. IL-8 and IL-10 may be involved in the occurrence and development of ovarian cancer. There are certain reference values on the changes of IL-8 and IL-10 levels, which may reflect the biological behavior and prognosis of ovarian cancer.Keywords
This publication has 19 references indexed in Scilit:
- Plasma immune analytes in patients with epithelial ovarian cancerCytokine, 2015
- Immunosuppression through constitutively activated NF-κB signalling in human ovarian cancer and its reversal by an NF-κB inhibitorBritish Journal of Cancer, 2014
- Identification of a three-gene expression signature of early recurrence in non-muscle-invasive urothelial cell carcinoma of the bladderUrologic Oncology: Seminars and Original Investigations, 2012
- Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patientsBMC Cancer, 2011
- The role of IL-10 in immune regulation during M. tuberculosis infectionMucosal Immunology, 2011
- Thrombin facilitates invasion of ovarian cancer along peritoneum by inducing monocyte differentiation toward tumor-associated macrophage-like cellsCancer Immunology, Immunotherapy, 2010
- Ovarian cancerThe Lancet, 2009
- Ovarian CancerAnnual Review of Pathology: Mechanisms of Disease, 2009
- Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancerGynecologic Oncology, 2006
- Multiplexed Immunobead-Based Cytokine Profiling for Early Detection of Ovarian CancerCancer Epidemiology, Biomarkers & Prevention, 2005